Artificial Intelligence in the Management of Chronic Diseases: Opportunities, Challenges, and Future Directions
Main Article Content
Keywords
artificial intelligence, chronic disease management, clinical decision support, remote patient monitoring, digital therapeutics
Abstract
Chronic diseases represent one of the foremost global health burdens, requiring long-term, coordinated strategies for management. Traditional chronic disease management models, primarily reliant on periodic follow-ups and acute medical interventions, often struggle to address the persistent and complex nature of chronic conditions. In recent years, artificial intelligence (AI) has been introduced as an emerging technology within chronic disease management, playing a significant role in continuous data monitoring, risk prediction, and clinical decision support methodologies. This paper systematically reviews the application of AI in chronic disease management, analysing the potential advantages, functional positioning, and current landscape. By synthesising existing research, it aims to investigate AI's functional role within chronic disease management. AI applications primarily concentrate on continuous monitoring and risk prediction, while also supporting clinician-assisted decision-making and remote health management. Overall, AI offers novel technological support for chronic disease management, yet AI development remains in a transitional phase from technical exploration to systemic integration. Further refinement is required in model interpretability, data security, and fairness. The key to transforming these auxiliary tools into integral components of long-term management systems lies in advancing the development of safe, reliable, and trustworthy AI.
References
- [1] Yach, D., Hawkes, C., Gould, C. L., & Hofman, K. J. (2004). The global burden of chronic diseases: Overcoming impediments to prevention and control. JAMA, 291(21), 2616–2622.
- [2] Bohr, A., & Memarzadeh, K. (2020). The rise of artificial intelligence in healthcare applications. In A. Bohr & K. Memarzadeh (Eds.), Artificial intelligence in healthcare (pp. 25–60). Academic Press. https://doi.org/10.1016/B978-0-12-818438-7.00002-2
- [3] Wagner, E. H. (2019). Organizing care for patients with chronic illness revisited. The Milbank Quarterly, 97(3), 659–664. https://doi.org/10.1111/1468-0009.12403
- [4] Al Kuwaiti, A., Nazer, K., Al-Reedy, A., Al-Shehri, S., Al-Muhanna, A., Subbarayalu, A. V., Al Muhanna, D., & Al-Muhanna, F. A. (2023). A review of the role of artificial intelligence in healthcare. Journal of Personalized Medicine, 13(6), 951. https://doi.org/10.3390/jpm13060951
- [5] Wasilewski, T., Kamysz, W., & Gębicki, J. (2024). AI-assisted detection of biomarkers by sensors and biosensors for early diagnosis and monitoring. Biosensors, 14(7), 356. https://doi.org/10.3390/bios14070356
- [6] Elvas, L., Almeida, A., & Ferreira, J. (2025). The role of AI in cardiovascular event monitoring and early detection: Scoping literature review. JMIR Medical Informatics, 13, e64349. https://doi.org/10.2196/64349
- [7] Di Nucci, E. (2024). AI-supported clinical decision-making. SSRN. https://doi.org/10.2139/ssrn.4851973
- [8] Gerdes, A. (2024). The role of explainability in AI-supported medical decision-making. Discover Artificial Intelligence, 4(1), 29.
- [9] Marier-Tétrault, E., Bebawi, E., Béchard, S., Brouillard, P., Zuchinali, P., Remillard, E., Carrier, Z., Jean-Charles, L., Nguyen, J. N. K., Lehoux, P., Pomey, M. P., Ribeiro, P. A. B., & Tournoux, F. (2024). Remote patient monitoring and digital therapeutics enhancing the continuum of care in heart failure: Nonrandomized pilot study. JMIR Formative Research, 8, e53444. https://doi.org/10.2196/53444
- [10] Shah, A. M., & Shah, S. V. (2023). Digital therapeutics—A new era in health care. National Journal of Physiology, Pharmacy and Pharmacology, 13(11), 2190–2196.
- [11] Du, Y., Yang, P., Liu, Y., Deng, C., & Li, X. (2025). Artificial intelligence in chronic disease self-management: Current applications and future directions. Frontiers in Public Health, 13, Article 1689911. https://doi.org/10.3389/fpubh.2025.1689911
- [12] Muthineni, S. R. (2025). AI in mobile health apps: Transforming chronic disease management. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 11(1), 108–116. https://doi.org/10.32628/CSEIT25111212
- [13] Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019). Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine, 17, 195. https://doi.org/10.1186/s12916-019-1426-2
- [14] Subramanian, M., Wojtusciszyn, A., Favre, L., Boughorbel, S., Shan, J., Letaief, K. B., Pitteloud, N., & Chouchane, L. (2020). Precision medicine in the era of artificial intelligence: Implications in chronic disease management. Journal of Translational Medicine, 18(1), 472. https://doi.org/10.1186/s12967-020-02658-5
- [15] World Health Organization. (n.d.). Noncommunicable diseases. https://www.who.int/health-topics/noncommunicable-diseases
- [16] Dixon, J., Lewis, R., Rosen, R., Finlayson, B., & Gray, D. (2004). Managing chronic disease: What can we learn from the US experience? The King’s Fund. https://www.kingsfund.org.uk/insight-and-analysis/reports/managing-chronic-disease
